FRACT-AI: A study comparing the finding of broken bones on X-Rays by artificial intelligence to the findings by clinicians of varying grades and professional backgrounds

ISRCTN ISRCTN19562541
DOI https://doi.org/10.1186/ISRCTN19562541
IRAS number 310995
ClinicalTrials.gov number NCT06130397
Secondary identifying numbers NIHR204982, IRAS 310995, CPMS 52221
Submission date
17/11/2023
Registration date
11/03/2024
Last edited
06/09/2024
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Some recent research has shown two things regarding how we look at x-rays to look for fractures, the first is that artificial intelligence (AI) shows that it can competently locate fractures, and the second is that in the emergency department, one of the most frequent problems is mistakes being made in locating fractures on x-rays.
This study brings those two things together, looking at how an AI performs in comparison to a human clinician, and further looks at how the human performs when helped by the AI. The human clinicians will represent several hospital professions (emergency medicine, orthopaedics, radiologists, radiology, physiotherapy and emergency nurses) and levels of experience ranging from junior staff to experienced consultant-level clinicians. The clinicians will look at 500 x-rays, of which half have a fracture, and half do not. The study will measure how many of them are correctly identified.

Who can participate?
Hospital professions (emergency medicine, orthopaedics, radiologists, radiology, physiotherapy and emergency nurses) in the trusts involved.

What does the study involve?
The study will begin recruitment at the start of September for eight weeks, with the first month of x-ray interpretation (where the participants don't have AI to help them) scheduled to begin on the 1st of November. After a period of time of one month (to reduce the chances of x-rays being remembered), the same x-rays will be looked at for a second time with the help of the AI.

What are the possible benefits and risks of participating?
There will be no risk to participants in this study. X-rays interpreted will be old x-rays that are not being used actively in the treatment of a patient.

Where is the study run from?
The study will occur over five NHS trusts in the Thames Deanery - Oxford University Hospitals, Royal Berkshire, Buckinghamshire Healthcare, Frimley Health and Milton Keynes University Hospital (UK)

When is the study starting and how long is it expected to run for?
December 2022 to June 2025

Who is funding the study?
National Institute for Health and Care Research (NIHR) (UK).

Who is the main contact?
Professor Alex Novak, alex.novak@ouh.nhs.uk
Doctor Sarim Ather, sarim.ather@ouh.nhs.uk

Contact information

Prof Alex Novak
Scientific, Principal Investigator

John Radcliffe Hospital, Headley Way, Headington
Oxford
OX3 9DU
United Kingdom

ORCiD logoORCID ID 0009-0006-4086-3152
Phone 0300 304 7777
Email alex.novak@ouh.nhs.uk
Dr Sarim Ather
Scientific, Principal Investigator

John Radcliffe Hospital, Headley Way, Headington
Oxford
OX3 9DU
United Kingdom

ORCiD logoORCID ID 0000-0001-9614-5033
Phone 0300 304 7777
Email sarim.ather@ouh.nhs.uk
Dr Max Hollowday
Public

John Radcliffe Hospital, Headley Way, Headington
Oxford
OX3 9DU
United Kingdom

ORCiD logoORCID ID 0009-0001-0288-954X
Phone 0300 304 7777
Email max.hollowday@nhs.net

Study information

Study designMulticentre multiple-reader multiple-case study
Primary study designObservational
Secondary study designMultiple-reader multiple-case study
Study setting(s)Internet/virtual, Medical and other records
Study typeDiagnostic
Participant information sheet 44612 PIS 0.2.pdf
Scientific titleFRACT-AI: Evaluating the Impact of Artificial Intelligence-Enhanced Image Analysis on the Diagnostic Accuracy of Frontline Clinicians in the Detection of Fractures on Plain X-Ray
Study acronymFRACT-AI
Study hypothesisPrevious research has demonstrated AI's promising diagnostic performance in the location of fractures, and similarly X-Ray interpretation in the emergency department has been found to be a frequent source of error. These elements have not yet been compared in a UK clinical setting. This study hypothesises that artificial intelligence (Boneview) is more accurate at accurately locating fractures on plain X-Rays than that those interpreted by human clinicians.
Ethics approval(s)

Approved 13/12/2022, UK Healthcare Research Authority (2 Redman Place, London, E20 1JQ, United Kingdom; +44 207 104 8000; queries@hra.nhs.uk), ref: R80145/RE001

ConditionLocation of fractures on plain X-rays by artificial intelligence and human clinicians.
InterventionThe study broadly compares X-ray interpretation between human clinicians and an artificial intelligence designed to locate fractures in plain x-rays - Boneview.

500 plain x-rays will be interpreted by each participant, 50% pathological and 50% normal. The reference for the 50:50 divide will be set by a panel of specialised musculoskeletal radiologists, each x-ray being reviewed by at least two musculoskeletal radiologists to establish 'ground truth'. There will also be additional parameters ascribed to each x-ray, including the nature of the pathological finding, the location of the anatomy being investigated, and the difficulty of the image to interpret.

Plain x-rays not to be included are:
-X-ray Skull
-X-ray Cervical spine
-Postsurgical X-ray
-Follow-up x-ray for known fracture
-Paediatric x-ray (<18 years)

The human clinicians, hereafter termed 'readers', will show a range of specialities and levels of experience. 18 clinicians in total will be split evenly between 6 specialities: emergency medicine physicians, surgeons in trauma & orthopaedics, radiologists, radiographers, physiotherapists, and finally emergency nurse practitioners (nurses specialising in minor trauma injuries in the emergency department). Within these groups, consisting of 3 clinicians each, there will be a person of consultant/equivalent level (>10 years' practice), registrar/equivalent (5-10 years' practice), and senior house officer/equivalent (>5 years' practice).

The images will be run through Boneview. The readers will then interpret the same set of randomised images twice, once without the aid of Boneview, and after a washout period of no less than a month, a second time with the assistance of Boneview.

The study will therefore compare AI on its own with unassisted readers, and with AI and readers working in synchrony. As a subset, data will also be collected on the professional background of the reader, and their level of experience.
Intervention typeDevice
Pharmaceutical study type(s)Not Applicable
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Gleamer Boneview
Primary outcome measureClinician readers will be asked to identify the presence or absence of fracture by placing a marker on the image at the location of the fracture (if present) and to rank their confidence for fracture identification. Confidence rating will take the form of a Likert scale from 1 to 10, 1 being least confident, 10 being very confident).
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date13/12/2022
Overall study end date30/06/2025

Eligibility

Participant type(s)Health professional
Age groupAdult
SexBoth
Target number of participants18
Total final enrolment16
Participant inclusion criteria1. Healthcare professional from the following professions/specialities:
1.1. Emergency medicine physicians
1.2. Surgeons in trauma and orthopaedics
1.3. Radiologists
1.4. Radiographers
1.5. Physiotherapists
1.6. Emergency nurse practitioners
Participant exclusion criteria1. Not from the above listed professions (emergency medicine physicians, surgeons in trauma and orthopaedics, radiologists, radiographers, physiotherapists, emergency nurse practitioners.)
2. Radiologists already musculoskeletal specialists,
Recruitment start date01/09/2023
Recruitment end date31/10/2023

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centres

Oxford University Hospitals NHS Foundation Trust
John Radcliffe Hospital
Headley Way
Headington
Oxford
OX3 9DU
United Kingdom
Royal Berkshire NHS Foundation Trust
Royal Berkshire Hospital
London Road
Reading
RG1 5AN
United Kingdom
Buckinghamshire Healthcare NHS Trust
Amersham Hospital
Whielden Street
Amersham
HP7 0JD
United Kingdom
Frimley Health NHS Foundation Trust
Portsmouth Road
Frimley
Camberley
GU16 7UJ
United Kingdom
Milton Keynes University Hospital NHS Foundation Trust
Standing Way
Eaglestone
Milton Keynes
MK6 5LD
United Kingdom

Sponsor information

NIHR Clinical Research Network
Government

Old Rd, Headington
Oxford
OX3 7LD
England
United Kingdom

Phone +44 1865 226764
Email enquiries@nihr.ac.uk
Website https://www.crn.nihr.ac.uk/
ROR logo "ROR" https://ror.org/05fj7ar22

Funders

Funder type

Government

National Institute for Health and Care Research
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom

Results and Publications

Intention to publish date01/04/2024
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publications in mind for this study are the British Medical Journal and the Emergency Medicine Journal
IPD sharing planThe current data sharing plans for this study are unknown and will be available at a later date

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version 0.2 01/12/2023 No Yes
Protocol file version 0.7 01/12/2023 No No
Protocol article 05/09/2024 06/09/2024 Yes No

Additional files

44612 FRACT-AI Protocol 0.7.pdf
44612 PIS 0.2.pdf

Editorial Notes

06/09/2024: Publication reference added.
03/05/2024: The overall study end date was changed from 31/03/2024 to 30/06/2025. Total final enrolment added.
01/12/2023: Trial's existence confirmed by the National Institute for Health and Care Research (NIHR) (UK).